02/03/2017 - 3:44pm

The Pharmaceutical Research and Manufacturers of America has announced leadership changes to some of its advocacy efforts as longtime SVP advocacy Jeff Bond is set to retire. 

02/02/2017 - 3:37pm
Diplomat acquired the company for $16 million in cash and up to an additional $4 million in contingent payments. 
02/02/2017 - 9:59am

Winter weather events, a slow cold and flu season and continued reimbursement pressure affected overall sales for Q4, fiscal year 2016 and January, however.

02/01/2017 - 1:42pm

Johnson & Johnson worldwide chairman, pharmaceuticals Joaquin Duato was elected chairman of the board, Novartis CEO Joseph Jimenez was elected chairman-elect and Amgen chairman and CEO Robert Bradway was named board treasurer.

01/27/2017 - 2:58pm

The new Walgreens specialty pharmacies are part of more than 250 Walgreens community and health system pharmacies that focus on community-based, patient-centered care.

01/27/2017 - 10:24am

Despite not seeking accelerated regulatory approval, company is moving forward with its development.

01/26/2017 - 10:05am

Actelion will spin off its drug discovery operations and early-stage clinical development assets into a newly created company to its shareholders in the form of a dividend immediately prior to the deal closing.

01/23/2017 - 12:40pm

The campaign is aimed at highlighting those in the industry driving innovation and pointing to the opportunity that exists in tackling complex health conditions. 

01/20/2017 - 3:28pm
The Food and Drug Administration approved the regimen of Opdivo and Yervoy as a treatment for metastatic melanoma in October 2015.